Santhera und Ipsen verhandeln Rechte an Fipamezole neu

Santhera erhält weltweite Rechte an Fipamezole * Ipsen behält Option auf weltweite Rechte unter bestimmten Bedingungen

(1 Download)

Pressure BioScience, Inc. Announces Global Co-Marketing/Selling and Instrument Co-Development Agreement with Digilab, Inc.

Leading Life Sciences Tools Manufacturers for the Research Laboratory to Collaborate in the Development, Marketing and Sale of State-of-the-Art Sample Preparations Products

(0 Downloads)

Europäische Kommission erteilt Biofrontera die EU-weite Zulassung für Ameluz

(0 Downloads)

Cenix BioScience, CYTOO and academic collaborators Bioquant, EPFL and FTMC receive a 4M€ EU FP7 grant to launch MEHTRICS consortium

New public-private consortium to further develop the power of high throughput, high content RNAi screening through convergence with micropatterning-based cell assays

(1 Download)

Biofrontera AG emittiert weitere Teilschuldverschreibungen der 5%-Optionsanleihe 2011/2016

(1 Download)